Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.59 |
| ▸ | NPC1 | O15118 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | CHAT | P28329 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | NPY1R | P25929 | 1/20 | 0.46 |
| ▸ | NPY2R | P49146 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14279418 | 1.00 | RAB9A (0.59) | RAB9ANPC1KMT2AMEN1ATM | |
| SCHEMBL21635044 | 0.84 | RAB9A (0.53) | RAB9ANPC1KMT2AMEN1ATM | |
| SCHEMBL29673969 | 0.83 | CHAT (0.49) | RAB9ACHATMAPTMAPK1KDM4E | |
| SCHEMBL318015 | 0.83 | CHAT (0.49) | RAB9ACHATMAPTMAPK1KDM4E | |
| SCHEMBL318014 | 0.83 | CHAT (0.49) | RAB9ACHATMAPTMAPK1KDM4E | |
| SCHEMBL8376769 | 0.83 | SMN1; SMN2 (0.46) | RAB9ANPC1KMT2AMEN1ATM | |
| SCHEMBL10706694 | 0.82 | CHAT (0.62) | RAB9ACHATKDM4EALDH1A1RXRA | |
| SCHEMBL10706700 | 0.82 | CHAT (0.62) | RAB9ACHATKDM4EALDH1A1RXRA | |
| SCHEMBL10706687 | 0.82 | CHAT (0.62) | RAB9ACHATKDM4EALDH1A1RXRA | |
| SCHEMBL30747848 | 0.81 | ALDH1A1 (0.50) | RAB9ACHATMAPTMAPK1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116410135-A | Naphthalene vinyl pyridine compound, photosensitive resin composition, application thereof and patterning method | 常州强力先端电子材料有限公司 | 2023-07-11 | — | — | CN | claimed |
| EP-1107063-B1 | Photobleachable compounds containing photopolymerizable compositions for use in flexographic printing plates | DU PONT (US) | 2010-03-10 | — | — | EP | claimed |
| US-6864039-B2 | Such as naphthylvinyl-pyridine; for improved heat stability and image resolution | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-03-08 | — | — | US | claimed |
| US-6846830-B2 | Naphtalene derivatives and their pharmaceutical use | ELI LILLY AND COMPANY (US) | 2005-01-25 | — | — | US | claimed |
| US-20030219681-A1 | Photobleachable compounds for use in flexographic printing plates | CHENG LAP KIN (US) | 2003-11-27 | — | — | US | claimed |
| JP-2003528856-A | — | — | 2003-09-30 | — | — | JP | claimed |
| US-20030073725-A1 | Naphtalene derivatives and their pharmaceutical use | ELI LILLY AND COMPANY | 2003-04-17 | — | — | US | claimed |
| EP-1272469-A1 | NAPHTHALENE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ELI LILLY AND COMPANY (US) | 2003-01-08 | — | — | EP | claimed |
| EP-1138328-A1 | Naphthalene derivatives as CNS drugs | ELI LILLY AND COMPANY LIMITED (GB) | 2001-10-04 | — | — | EP | claimed |
| WO-2001072709-A1 | NAPHTALENE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ELI LILLY AND COMPANY (US) | 2001-10-04 | — | — | WO | claimed |
| EP-1107063-A1 | Photobleachable compounds containing photopolymerizable compositions for use in flexographic printing plates | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-06-13 | — | — | EP | claimed |
| EP-3674372-B1 | INK, INK FOR INK-JET RECORDING, PRINTED MATTER, AND METHOD FOR PRODUCING PRINTED MATTER | DAINIPPON INK & CHEMICALS (JP) | 2025-04-23 | — | — | EP | disclosed |
| US-12264251-B2 | Ink, ink for ink-jet recording, printed matter, and method for producing printed matter | DIC CORPORATION (JP) | 2025-04-01 | — | — | US | disclosed |
| CN-117794645-A | Culture medium for hydroponics, method for producing culture medium for hydroponics, hydroponics method using culture medium for hydroponics, and dispersion for inhibiting algae production | DIC株式会社 | 2024-03-29 | — | — | CN | disclosed |
| US-20240076514-A1 | INK, INK FOR INK-JET RECORDING, PRINTED MATTER, AND METHOD FOR PRODUCING PRINTED MATTER | DIC CORPORATION (JP) | 2024-03-07 | — | — | US | disclosed |
| EP-1272469-A1 | NAPHTHALENE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ELI LILLY AND COMPANY (US) | 2003-01-08 | — | — | EP | disclosed |
| EP-1138328-A1 | Naphthalene derivatives as CNS drugs | ELI LILLY AND COMPANY LIMITED (GB) | 2001-10-04 | — | — | EP | disclosed |
| WO-2001072709-A1 | NAPHTALENE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ELI LILLY AND COMPANY (US) | 2001-10-04 | — | — | WO | disclosed |
| JP-2001209174-A | PHOTO-BLEACHABLE COMPOUND USED FOR FLEXOGRAPHIC PRINTING PLATE | E I DU PONT DE NEMOURS & CO | 2001-08-03 | — | — | JP | disclosed |
| EP-1107063-A1 | Photobleachable compounds containing photopolymerizable compositions for use in flexographic printing plates | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073725-A1 | Naphtalene derivatives and their pharmaceutical use | CHRNA6, ATP6V1B2, GRM6 | RAB9A 3682/4885NPC1 914/4885KMT2A 2182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.